"/> Novus Biologicals™ Peptide bloquant d’anticorps AT… | B-LABO France

Novus Biologicals™ Peptide bloquant d’anticorps ATAD3A

Réf. : BL-RE-043883Réf. fabricant : 18250816 0.05 mg
201,94 € HT

Highly purified. Generating reliable and reproducible results. Applications: Antibody Competition

Gene ID (Entrez)
55210
Espèces
Human
Contenu et stockage
Store at -20 C. Avoid freeze-thaw cycles.
Formule
PBS pH 7.2 (10 mM NaH2PO4, 10 mM Na2HPO4, 130 mM NaCl) containing 0.1% bovine serum albumin.
À utiliser avec (application)
This Peptide is Useful as a Blocking Peptide for NBP1-76586. For Further Blocking Peptide Related Protocol, Click Here .
Marque
Novus Biologicals

A blocking peptide containing 19 amino acids near the amino terminus of human ATAD3A.

Points forts

Source

Synthetic

(Accession #: Q9NVI7) The ATAD3A Blocking Peptide has been validated for the following applications: Antibody Competition.

Caractéristiques techniques

MarqueNovus Biologicals
Réf. B-LABOBL-RE-043883
Réf. fabricant18250816
Gene ID (Entrez)55210
EspècesHuman
Contenu et stockageStore at -20 C. Avoid freeze-thaw cycles.
FormulePBS pH 7.2 (10 mM NaH2PO4, 10 mM Na2HPO4, 130 mM NaCl) containing 0.1% bovine serum albumin.
À utiliser avec (application)This Peptide is Useful as a Blocking Peptide for NBP1-76586. For Further Blocking Peptide Related Protocol, Click Here .
Alias de gèneATPase family AAA domain-containing protein 3 A, ATPase family, AAA domain containing 3 A, FLJ10709, FLJ35514
Symbole de gène(s)ATAD3A
Type de produitATAD3A
Quantité0.05 mg
État réglementaireRUO - research use only
SourceSynthetic
Consigne19 amino acids near the amino terminus of human ATAD3A
Une question, une configuration particulière ?
Contactez-nous pour un devis.